Tag: Hydromethylthionine
TauRx Hydromethylthionine Mesylate (HMTM) Shows Significant Reduction in Neurodegeneration in Alzheimer’s (AD) – 07/16/2023
TauRx Pharmaceuticals Ltd., a global leader in tau-based research in Alzheimer’s disease (AD), today announced results from a pre-specified analysis of the Phase 3 LUCIDITY study. The study measured the…